Literature DB >> 33148679

Regulatory T Cells Play an Important Role in the Prevention of Murine Melanocytic Nevi and Melanomas.

Laura Timares1, Craig A Elmets2,3, Tahseen H Nasti1, Nabiha Yusuf1,3, Mohammad Asif Sherwani1, Mohammad Athar1.   

Abstract

Melanocytic nevi are benign proliferations of pigment cells that can occasionally develop into melanomas. There is a significant correlation between increased nevus numbers and melanoma development. Our previous reports revealed that 7,12-dimethylbenz(a)anthracene (DMBA) and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) induced dysplastic nevi in C3H/HeN mice, with a potential to transform into melanomas. To understand the immune mechanisms behind this transformation, we applied increasing DMBA doses followed by TPA to the skin of C3H/HeN mice. We observed that increased doses of DMBA correlated well with increased numbers of nevi. The increased DMBA dose induced diminished immune responses and promoted the expansion of regulatory T cells (Treg) that resulted in increased IL10 and reduced IFNγ levels. Mice with increased nevus numbers had loss of p16 expression. These mice had increased migration of melanocytic cells to lymph nodes (LN) and a greater percent of LNs produced immortalized melanocytic cell lines. DMBA-induced immunosuppression was lost in CD4-knockout (KO) mice. Lymphocytes in the CD4KO mice produced less IL10 than CD8KO mice. Furthermore, CD4KO mice had significantly reduced nevus numbers and size compared with wild-type and CD8KO mice. These results suggest that Tregs play a vital role in the incidence of nevi and their progression to melanoma.Prevention Relevance: There has been little progress in developing novel strategies for preventing premalignant dysplastic nevi from becoming melanomas. In this study in mice, regulatory-T cells enhanced progression of benign nevi to malignant melanomas; and by inhibiting their activity, melanomas could be retarded. The findings identify new possibilities for melanoma prevention in high risk individuals. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33148679      PMCID: PMC8093326          DOI: 10.1158/1940-6207.CAPR-20-0360

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  42 in total

1.  Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway.

Authors:  Janet L Maldonado; Luika Timmerman; Jane Fridlyand; Boris C Bastian
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

2.  The DNA damage response induces IFN.

Authors:  Sabrina Brzostek-Racine; Chris Gordon; Sarah Van Scoy; Nancy C Reich
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

3.  p16 expression in primary malignant melanoma is associated with prognosis and lymph node status.

Authors:  Daniela Mihic-Probst; Christian D Mnich; Patrick A Oberholzer; Burkhardt Seifert; Bernd Sasse; Holger Moch; Reinhard Dummer
Journal:  Int J Cancer       Date:  2006-05-01       Impact factor: 7.396

4.  Identification of BRAF mutations in eruptive melanocytic nevi: new insights into melanomagenesis?

Authors:  Jobin K John; Keiran S M Smalley
Journal:  Expert Rev Anticancer Ther       Date:  2011-05       Impact factor: 4.512

5.  Familial and cutaneous features of dysplastic nevi: a case-control study.

Authors:  M A Tucker; W A Crutcher; P Hartge; R W Sagebiel
Journal:  J Am Acad Dermatol       Date:  1993-04       Impact factor: 11.527

6.  Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells.

Authors:  Martin Guilliams; Karine Crozat; Sandrine Henri; Samira Tamoutounour; Pierre Grenot; Elisabeth Devilard; Béatrice de Bovis; Lena Alexopoulou; Marc Dalod; Bernard Malissen
Journal:  Blood       Date:  2010-01-12       Impact factor: 22.113

Review 7.  Non-melanoma skin cancer in mouse and man.

Authors:  Michael Schwarz; Peter A Münzel; Albert Braeuning
Journal:  Arch Toxicol       Date:  2012-12-25       Impact factor: 5.153

Review 8.  CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.

Authors:  Masao Hashimoto; Alice O Kamphorst; Se Jin Im; Haydn T Kissick; Rathi N Pillai; Suresh S Ramalingam; Koichi Araki; Rafi Ahmed
Journal:  Annu Rev Med       Date:  2018-01-29       Impact factor: 13.739

Review 9.  Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment.

Authors:  Svetomir N Markovic; Lori A Erickson; Ravi D Rao; Roger H Weenig; Barbara A Pockaj; Aditya Bardia; Celine M Vachon; Steven E Schild; Robert R McWilliams; Jennifer L Hand; Susan D Laman; Lisa A Kottschade; William J Maples; Mark R Pittelkow; Jose S Pulido; J Douglas Cameron; Edward T Creagan
Journal:  Mayo Clin Proc       Date:  2007-04       Impact factor: 7.616

10.  Immune enhancement of skin carcinogenesis by CD4+ T cells.

Authors:  Dylan Daniel; Nicole Meyer-Morse; Emily K Bergsland; Kerstin Dehne; Lisa M Coussens; Douglas Hanahan
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

View more
  1 in total

Review 1.  Vaccination against Cancer or Infectious Agents during Checkpoint Inhibitor Therapy.

Authors:  Tahseen H Nasti; Christiane S Eberhardt
Journal:  Vaccines (Basel)       Date:  2021-11-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.